Home / Japan / Shin Nippon Biomedical Laboratories,ltd.

Shin Nippon Biomedical Laboratories,ltd.

Short position disclosed on September 14, 2026.

0.59% of the capital sold short

1 disclosing fund

20 disclosures on record

Evolution of the disclosed total

0%0.5%1%1.5%2%

Aug 12Aug 21Aug 30Sep 8Sep 17

Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.

Open positions

The funds disclosing a short position that is still open.
Fund	Twelve months	% of capital	Over the year	Since
Goldman Sachs International		0.59%	new	September 14, 2026

Follow by RSS

Get the moves on Shin Nippon Biomedical Laboratories,ltd. by mail.

No account: one address, one link to confirm, one link to stop in every message.

History of disclosures

20 disclosures on record for this share.
Date	Fund	% of capital	End of publication
September 14, 2026	Goldman Sachs International	0.59%	still open
September 11, 2026	Goldman Sachs International	0.63%
September 10, 2026	Goldman Sachs International	0.59%
September 9, 2026	Barclays Capital Securities Ltd	0.85%
September 9, 2026	UBS AG	0.23%
September 7, 2026	Goldman Sachs International	0.64%
September 7, 2026	UBS AG	0.52%
September 4, 2026	Barclays Capital Securities Ltd	0.57%
August 31, 2026	Barclays Capital Securities Ltd	0.60%
August 31, 2026	Goldman Sachs International	0.53%
August 28, 2026	Goldman Sachs International	0.61%
August 21, 2026	Goldman Sachs International	0.55%
August 12, 2026	Goldman Sachs International	0.68%
August 12, 2026	Barclays Capital Securities Ltd	0.58%
August 10, 2026	Barclays Capital Securities Ltd	0.60%
August 6, 2026	Goldman Sachs International	0.74%
August 6, 2026	Barclays Capital Securities Ltd	0.52%
August 5, 2026	Goldman Sachs International	0.82%
August 4, 2026	Goldman Sachs International	0.78%
August 3, 2026	UBS AG	0.48%

Download 20 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in Japan

ReYuu Japan Inc. 13.43% of the capital sold short
Nissay ETF TOPIX(Quarterly settlement type) 12.58% of the capital sold short
QD Laser,Inc. 10.81% of the capital sold short
SHIFT Inc. 10.44% of the capital sold short
W-SCOPE Corporation 9.86% of the capital sold short
Towa Corporation 9.12% of the capital sold short
Tri Chemical Laboratories Inc. 8.66% of the capital sold short
Sanrio Company,Ltd. 8.51% of the capital sold short
Toyo Engineering Corporation 8.13% of the capital sold short
Jibannet Holdings Co.,Ltd. 8.07% of the capital sold short
Metaplanet Inc. 7.92% of the capital sold short
AKIBA Holdings Co.,Ltd. 7.83% of the capital sold short

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Shin Nippon Biomedical Laboratories,ltd., source JPX, data as at September 14, 2026, https://www.quivad.com/action/shin-nippon-biomedical-laboratories-ltd